Concurrent chemoradiotherapy with cyclophosphamide, pirarubicin, and cisplatin for patients with locally advanced salivary gland carcinoma

References

• Piechocki M, Lonardo F, Ensley JF, Nguyen T, Kim H, Yoo GH. Anticancer activity of docetaxel in murine salivary gland carcinoma. Clin Cancer Res 2002; 8: 870–7
   PubMed Web of Science ®Google Scholar
• Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2807 patients. Head Neck Surg 1986; 8: 177–84
   PubMedGoogle Scholar
• Spiro RH, Armstrong J, Harrison L, Geller NL, Lin SY, Strong EW. Carcinoma of major salivary glands. Recent trends. Arch Otolaryngol Head Neck Surg 1989; 115: 316–21
   PubMedGoogle Scholar
• Kane WJ, McCaffrey TV, Olsen KD, Lewis JE. Primary parotid malignancies. A clinical and pathologic review. Arch Otolaryngol Head Neck Surg 1991; 117: 307–15
   PubMedGoogle Scholar
• North CA, Lee DJ, Piantadosi S, Zahurak M, Johns ME. Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1990; 18: 1319–26
   PubMed Web of Science ®Google Scholar
• Suen JY, Johns ME. Chemotherapy for salivary gland cancer. Laryngoscope 1982; 92: 235–9
   PubMed Web of Science ®Google Scholar
• Kaplan JM, Johns ME, Cantrell RW. Chemotherapy for salivary gland cancer. Otolaryngol Head Neck Surg 1986; 95: 165–70
   PubMed Web of Science ®Google Scholar
• Venook AP, Tseng A, Jr, Meyers FJ. Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group. J Clin Oncol 1987; 5: 951–5
   PubMed Web of Science ®Google Scholar
• Dreyfuss AL, Clark JR, Fallon BG. Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin. Cancer 1987; 60: 2869–72
   PubMed Web of Science ®Google Scholar
• Creagan ET, Woods JE, Schutt AJ. Cyclophosphamide, adriamycin, and cis-diamminedichloro-platinum (II) in the treatment of advanced nonsquamous cell head and neck cancer. Cancer 1983; 52: 2007–10
   PubMed Web of Science ®Google Scholar
• Triozzi PL, Brantley A, Fisher S. 5-Fluorouracil, cyclophosphamide, and vincristine for adenoid cystic carcinoma of the head and neck. Cancer 1987; 59: 887–90
   PubMed Web of Science ®Google Scholar
• Tsukuda M, Kokatsu T, Ito K, Mochimatsu I, Kubota A, Sawaki S. Chemotherapy for recurrent adeno- and adenoidcystic carcinomas in the head and neck. J Cancer Res Clin Oncol 1993; 119: 756–58
   PubMed Web of Science ®Google Scholar
• Tsukuda M, Mikami Y, Tanigaki Y, Katori H, Horiuchi C, Ikeda Y. Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck. Int J Clin Oncol 2004; 9: 161–6
   PubMedGoogle Scholar
• Katori H, Tsukuda M, Mochimatu I, Ishitoya J. Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Br J Cancer 2004; 90: 348–52
   PubMed Web of Science ®Google Scholar
• Katori H, Tsukuda M. Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck. Clin Oncol 2005; 17: 148–52
   PubMedGoogle Scholar
• World Health Organization (WHO). Handbook for reporting results of cancer treatment. WHO offset publication no. 48. World Health Organization, GenevaSwitzerland 1979
   Google Scholar
• Inuyama Y, Kida A, Tsukuda M. Late phase II study of S-1 in patients with advanced head and neck cancer. Jpn J Cancer Chemother 2001; 28: 1381–90
   PubMedGoogle Scholar
• Rentschler R, Burgess MA, Byers R. Chemotherapy of malignant major salivary gland neoplasms. A 25-year review of M.D. Anderson Hospital experience. Cancer 1977; 40: 619–24
   PubMed Web of Science ®Google Scholar
• Licitra L, Marchini S, Spinazze′ S, Rossi A, Rocca A, Grandi C. Cisplatin in advanced salivary gland carcinoma. A phase II study of 25 patients. Cancer 1991; 68: 1874–7
   PubMed Web of Science ®Google Scholar
• Tannock IF, Sutherland DJ. Chemotherapy for adenoid cystic carcinoma. Cancer 1980; 46: 452–4
   PubMed Web of Science ®Google Scholar
• Airoldi M, Brando V, Giordano C, Gabriele P, Bussi M, Cortesina G. Chemotherapy for recurrent salivary gland malignancies: experience of the ENT Department of Turin University. ORL J Otorhinolaryngol Relat Spec 1994; 56: 105–11
   PubMed Web of Science ®Google Scholar
• Posner MR, Ervin TJ, Weichselbaum RR. Chemotherapy of advanced salivary gland neoplasms. Cancer 1982; 50: 2261–4
   PubMed Web of Science ®Google Scholar
• Alberts DS, Manning MR, Coulthard SW. Adriamycin/cisplatin/cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid gland. Cancer 1981; 47: 645–8
   PubMed Web of Science ®Google Scholar
• Eisenberger MA. Supporting evidence for an active treatment program for advanced salivary gland carcinoma. Cancer Treat Rep 1985; 69: 319–21
   PubMedGoogle Scholar
• Creagan ET, Woods JE, Rubin J. Cisplatinbased chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neck. Cancer 1988; 62: 2313–19
   PubMed Web of Science ®Google Scholar
• Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma. Lancet 2000; 355: 949–55
   PubMed Web of Science ®Google Scholar
• Bernier J, van Gladdeke M. Result of EORTIC phase III trial 22931 comparing, postoperatively, radiotherapy to concurrent chemo-radiotherapy with high dose cisplatin in locally advanced head and neck carcinomas. Eur J Cancer 2001; 37(Suppl 6)S267
   Google Scholar
• Cooper JS, Pajak TF, Forastiere AA. Postoperative concurrent radiochemotherapy in high risk SCCA of the head and neck: initial report of RTOG 9501/intergroup phase III trial. Proc Am Soc Clin Oncol 2002; 21: 226
   Google Scholar
• Taylor SG 4th, Murthy AK, Vannetzel JM, Colin P, Dray M, Caldarelli DD, et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 1994; 12: 385–95
   PubMed Web of Science ®Google Scholar
• Airoldi M, Gabriele AM, Gabriele P, Pedani F, Marchionatti S, Succo G, et al. Concomitant chemoradiotherapy followed by adjuvant chemotherapy in parotid gland undifferentiated carcinoma. Tumori 2001; 87: 14–17
   PubMed Web of Science ®Google Scholar